News | April 16, 2014

Covidien Implements Voluntary Recall of its Pipeline Embolization Device and Alligator Retrieval Device

April 16, 2014 — Covidien announced it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolization device and Alligator retrieval device, where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate and detach from the devices.

PTFE coating is used to reduce friction between devices and ease navigation through the vasculature. Delamination of the PTFE coating could potentially lead to embolic occlusion in the cerebral vasculature with the risk of stroke and/or death.

Covidien learned of this issue through internal product testing. The company has not received any reports of patient injuries to date related to this issue.

The Pipeline embolization device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide?necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments. The Alligator retrieval device is intended for use in the peripheral and neuro?vasculature for foreign body retrieval.

A total of 32 Pipeline embolization devices and 621 Alligator retrieval devices are affected by this recall. The products were manufactured and distributed from May 2013 to March 2014. This issue involves both the Pipeline embolization device sold in the United States, Australia, France, Germany and United Kingdom, and the Alligator retrieval device sold in the United States, Australia, Canada, Europe and Latin America.

Covidien alerted customers to the recall by letter on April 1, 2014, and is arranging for replacement of the recalled products. The U.S. Food and Drug Administration (FDA) and other regulatory bodies also have been notified.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

For more information: www.covidien.com


Related Content

News | Stroke

Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...

Home November 18, 2024
Home
News | Stroke

Oct. 24, 2024 – Royal Philips and Medtronic Neurovascular have announced a strategic advocacy partnership. Delivering ...

Home October 24, 2024
Home
News | Stroke

Sept. 10, 2024 — Royal Philips and the World Stroke Organization (WSO) have published a policy paper calling for a ...

Home September 10, 2024
Home
News | Stroke

Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can ...

Home August 26, 2024
Home
News | Stroke

According to research published in Stroke, the peer-reviewed scientific journal of the American Stroke Association, one ...

Home August 09, 2024
Home
News | Stroke

June 7, 2024 — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion ...

Home June 07, 2024
Home
Feature | Stroke | By Pamela W. Duncan, PhD

Stroke recovery is a challenging process that extends for months after hospital discharge. Issues like cognitive ...

Home June 04, 2024
Home
News | Stroke

May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the ...

Home May 20, 2024
Home
News | Stroke

May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic ...

Home May 16, 2024
Home
News | Stroke

May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens ...

Home May 07, 2024
Home
Subscribe Now